Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 735 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Climb Bio, Inc.
Market Cap
$633.33M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$633.99M
Net Profit Margin
-4613.11%
TTM Avg
-5454.52%
3Y Avg
-2727.26%
5Y Avg
-1829.08%
Market Cap
$636.13M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$650.93M
Net Profit Margin
-115.18%
TTM Avg
-291.05%
3Y Avg
-192.01%
5Y Avg
-153.55%
Market Cap
$705.14M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$605.73M
Net Profit Margin
-11.48%
TTM Avg
-11.55%
3Y Avg
-24.81%
5Y Avg
-19.75%
Market Cap
$600.01M
Net Profit Margin
33.36%
TTM Avg
4.18%
3Y Avg
-43.84%
5Y Avg
-3.40%
Market Cap
$670.10M
Net Profit Margin
1.76%
TTM Avg
11.88%
3Y Avg
8.37%
5Y Avg
1.42%
Market Cap
$672.52M
Net Profit Margin
-194.74%
TTM Avg
-217471.40%
3Y Avg
-109716.20%
5Y Avg
-73279.44%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Climb Bio, Inc. (CLYM) | $633.33M | 0.00% | 0.00% | 0.00% | 0.00% |
| Prime Medicine, Inc. (PRME)vs › | $633.99M | -4613.11% | -5454.52% | -2727.26% | -1829.08% |
| Aura Biosciences, Inc. (AURA)vs › | $636.13M | 0.00% | 0.00% | 0.00% | 0.00% |
| OmniAb, Inc. (OABI)vs › | $650.93M | -115.18% | -291.05% | -192.01% | -153.55% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $705.14M | 0.00% | 0.00% | 0.00% | 0.00% |
| AngioDynamics, Inc. (ANGO)vs › | $605.73M | -11.48% | -11.55% | -24.81% | -19.75% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $600.01M | 33.36% | 4.18% | -43.84% | -3.40% |
| MiMedx Group, Inc. (MDXG)vs › | $670.10M | 1.76% | 11.88% | 8.37% | 1.42% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $672.52M | -194.74% | -217471.40% | -109716.20% | -73279.44% |
| Fulgent Genetics, Inc. (FLGT)vs › | $593.40M | -26.05% | -16.91% | -17.17% | 5.54% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
